The healthcare industry has been one of the strongest drivers of GDP growth in recent decades, which has translated into massive returns for healthcare stocks.
Keep Reading →
February 6 - Hedge Fund Analysis, Hedge Funds, News - Comments
In this article we’ll check out the Top 5 Stocks Warren Buffett Just Bought.
Keep Reading →
November 27 - Hedge Fund Analysis, Hedge Funds, News - Comments
Eric Chung, chief investment officer of Lighthaven Capital Management, joined the Contrarian Investor Podcast to discuss his view that math, financial models, and algorithms are...
Keep Reading →
August 10 - Hedge Funds, Insider Trading - Comments
NEW YORK (Reuters) - Billionaire investor Steve Cohen’s Point72 Ventures has invested in a U.S.
Keep Reading →
February 20 - Hedge Funds, Insider Trading - Comments
Billionaire Dan Loeb, the founder of $18 billion hedge fund Third Point, is mired in a fourth-straight year of trailing the market, though the activist fund did return a solid...
Keep Reading →
December 20 - Hedge Fund Analysis, Hedge Funds, News - Comments
Fisher Investments was founded in 1979 by billionaire Ken Fisher.
Keep Reading →
November 13 - Dividend Stocks, Hedge Funds, News - Comments
Liberal billionaire Tom Steyer claims to be building a juggernaut political operation in support of impeaching President Trump, rallying the base and creating a "digital army" ...
Keep Reading →
October 19 - Hedge Funds, Insider Trading - Comments
Andreas Halvorsen’s Viking Global Investors disclosed Thursday that it holds a 75.6% stake in urologic biopharmaceutical company Urovant Sciences Ltd.
Keep Reading →
October 12 - Hedge Funds, Insider Trading - Comments
Tesla Motors Inc (NASDAQ:TSLA) CEO Elon Musk has made amends with investors of his company after a poorly handled earnings call last week sent shares of the electric automaker...
Keep Reading →
May 8 - Insider Trading, News, Tech - Comments
On Tuesday before the market opened, shares of Merck & Co ($MRK) were gapping up on news of positive results from their lung cancer trial.
Keep Reading →
January 16 - Market Movers, News - Comments
Opus Point Partners was founded by Michael S. Weiss and Dr. Lindsay A. Rosenwald in 2009. Prior to launching Opus Point Partners, Mr. Weiss and Dr.
Keep Reading →
August 25 - Hedge Funds, News - Comments
If you're seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the 15 biggest healthcare companies...
Keep Reading →
July 6 - News - Comments
Healthcare is a vast sector that nonetheless has huge growth prospects, with the U.S government and its citizens spending about $3 trillion annually in an attempt to stay healthy...
Keep Reading →
May 3 - Hedge Funds, News - Comments
Merck & Co. Inc. (NYSE:MRK) entered the markets on April 7 in green, amid a thumbs down from the U.S.
Keep Reading →
April 7 - News - Comments
Reports indicate that there are a number of plaintiffs filing lawsuits against Merck & Co., Inc.
Keep Reading →
March 16 - News, Stock Analysis - Comments
The U.S. Food and Drug Administration (FDA) has acknowledged the filing for review of three New Drug Applications (NDAs) from Merck & Co., Inc. (NYSE:MRK) and Pfizer Inc.
Keep Reading →
March 8 - News, Stock Analysis - Comments
Merck & Co., Inc. (NYSE:MRK) has announced that it will be writing down approximately $2.9 billion following the shrinking of the market for a hepatitis drug it owns.
Keep Reading →
February 24 - News, Stock Analysis - Comments
A few weeks ago, President Donald Trump met with a series of biotech CEOs to discuss a historically major pain point for the industry: cutting the FDA drug approval process "at...
Keep Reading →
February 23 - News, Stock Analysis - Comments
Reports indicate that the market for immuno-oncology drugs could grow to $25 billion in the next ten years.
Keep Reading →
February 21 - News, Stock Analysis - Comments
Patients with bladder cancer now having something to smile about, after the acceptance of 2 new supplemental biologics license applications, by the FDA.
Keep Reading →
February 7 - News, Stock Analysis - Comments
The European Commission has approved KEYTRUDA® (pembrolizumab), an anti-PD-1 therapy from Merck & Co., Inc. (NYSE:MRK).
Keep Reading →
February 1 - News, Stock Analysis - Comments
United States President Donald Trump is urging US drugmakers to consider manufacturing more of their drugs in the United States, thinking that higher cost manufacturing at the...
Keep Reading →
February 1 - News, Stock Analysis - Comments
Merck & Co., Inc. (NYSE:MRK) is one of the pharma industry titans that are currently on the receiving end as a result of exaggerated drug price hikes.
Keep Reading →
January 30 - News, Stock Analysis - Comments
Merck & Co., Inc. (NYSE:MRK) has agreed to share a portion of Keytruda sales with Bristol-Myers Squibb Co (NYSE:BMY) and Ono Pharmaceutical Co., Ltd.
Keep Reading →
January 24 - News, Stock Analysis - Comments
Palantir Technologies Inc and Merck & Co., Inc.
Keep Reading →
January 18 - News, Stock Analysis - Comments
The problem of obesity is a modern one, with large sections of the global population becoming overweight late in the 20th century and into the 21st, and the prevalence is especially...
Keep Reading →
January 17 - Lists, News - Comments
Stanley Druckenmiller was one of the fund managers for the Quantum Fund founded by George Soros.
Keep Reading →
December 23 - Dividend Stocks, Hedge Funds, News - Comments
Individual lung cancer patients may soon be able to benefit from Keytruda, an immunotherapy drug from Merck & Co., Inc. (NYSE:MRK).
Keep Reading →
December 2 - News, Stock Analysis - Comments
The Dow Jones Industrial Average (DJIA) comprises of 30 companies representing a diverse collection of stocks from all market sectors.
Keep Reading →
November 30 - Hedge Funds, News - Comments
Stanley Druckenmiller is an American hedge fund manager who ran the $12 billion Duquesne Capital till 2010.
Keep Reading →
November 21 - Hedge Funds, News - Comments
OpGen Inc (NASDAQ:OPGN), a Market Exclusive favorite, earlier this week announced that it is bolstering its already long-standing relationship with pharmaceutical giant Merck...
Keep Reading →
November 17 - News, Stock Analysis - Comments
Adage Capital Management is a Boston-based hedge fund founded in 2001 by Phil Gross and Robert Atchinson.
Keep Reading →
November 15 - Hedge Fund Analysis, Hedge Funds, News - Comments
Kahn Brothers is a New York-based hedge fund which was founded by famous American businessman Irving Kahn (who recently passed away at the age of 109 as the Oldest Money Manager...
Keep Reading →
November 8 - Hedge Fund Analysis, Hedge Funds, News - Comments
The US Food and Drug Administration (FDA) has recently approved the anti-programmed-death-receptor-1 (anti-PD-1) therapy of Merck & Co., Inc.
Keep Reading →
October 26 - News, Stock Analysis - Comments
The pharmaceutical giant intends to lay off employees in two waves, the first of which is set next month and the other one in December.
Keep Reading →
October 6 - News, Stock Analysis - Comments
Back on May 12, 2015, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee released a briefing document detailing the process...
Keep Reading →
August 29 - News, Stock Analysis - Comments
Bourgeon Capital Management LLC, founded by John A.
Keep Reading →
August 3 - Hedge Fund Analysis, Hedge Funds, News - Comments
The U.S. dollar is stronger in early Wednesday activity as traders look forward to today's release of the domestic employment report.
Keep Reading →
August 3 - Earnings Report, Market Movers, News - Comments
U.S. stock futures are flat this morning following a decline in crude prices over worries surrounding renewed oversupply.
Keep Reading →
July 29 - Earnings Report, Market Movers, News - Comments
On July 23, the Food and Drug Administration will make its decision on bezlotoxumab, brand name Zinplava, a Merck & Co., Inc.
Keep Reading →
July 22 - News, Stock Analysis - Comments
Imagine the following scenario. A patient walks into a hospital with an infectious disease. He sees a physician or a nurse, who diagnoses him, usually on a hunch.
Keep Reading →
July 19 - News, Stock Analysis - Comments
At the turn of the millennium, the population of the United States clocked in at 282.2 million.
Keep Reading →
June 22 - News, Stock Analysis - Comments
All three index futures are in the red in this morning's pre-market as traders worry about a potential Brexit.
Keep Reading →
June 10 - Market Movers, News - Comments
Oil baron and America's first billionaire John D.
Keep Reading →
May 28 - Dividend Stocks, Hedge Funds, News - Comments
Kahn Brothers Group is a New York-based hedge fund firm founded by Irving Kahn, Thomas Graham Kahn and Alan Kahn in 1978.
Keep Reading →
May 14 - Hedge Fund Analysis, Hedge Funds, News - Comments
The US Stock market is trading higher on Thursday, helped by a 3% growth in Brent and WTI.
Keep Reading →
May 5 - Hedge Funds, News - Comments
HealthInvest Partners is a Stockholm-based fund management company founded by Carl Bennet and Anders Hallberg in 2006.
Keep Reading →
April 23 - Hedge Funds, News - Comments
The Kahn Brothers Group, formerly known as Kahn Brothers & Company Inc., was founded in 1978 by renowned investor Irving Kahn, who died last year at the age of 109.
Keep Reading →
February 11 - Hedge Fund Analysis, Hedge Funds, News - Comments
John A. Zaro, a Stanford graduate and a member of the New York Society of Security Analysts, founded Bourgeon Capital in 1999.
Keep Reading →
November 4 - Hedge Fund Analysis, Hedge Funds, News - Comments